WHO report flags India among top countries reporting measles outbreaks; campaign targets elimination by 2026
Provisional data reported to the WHO placed India among the countries with major measles outbreaks, with thousands of cases reported in 2025. India’s health authorities have linked elimination goals to stronger surveillance and immunisation coverage through a national measles-rubella campaign.
Measles resurgence and what the data shows
A report drawing on provisional data reported to the World Health Organization (WHO) has placed India among the countries significantly affected by measles outbreaks, with 8,035 cases cited for the April–October 2025 window. The numbers add to global concern about measles resurgence, which tends to follow gaps in immunisation coverage and disruptions in routine health services.

Measles remains highly contagious, and outbreaks can expand rapidly when immunity levels fall below thresholds required to prevent transmission. Public health experts routinely stress that even communities with generally good vaccination rates can see clusters if pockets of under-immunisation exist, especially in high-density settings or where healthcare access is inconsistent.
India’s elimination push and surveillance focus
India has framed its response around a national measles-rubella elimination effort, with a campaign positioned to strengthen coverage and close last-mile gaps. Officials have emphasised the importance of improving surveillance through the Integrated Disease Surveillance Programme (IDSP), rapidly identifying suspected cases and ensuring timely outbreak response to prevent local flare-ups from becoming wider transmission chains.
Health authorities have also highlighted district-level progress, pointing to large numbers of districts reporting zero measles and zero rubella cases in early 2025. At the same time, the resurgence signal indicates that gains can be fragile if routine immunisation slips in specific geographies or among mobile and hard-to-reach populations.
Why immunisation coverage still matters
Under India’s Universal Immunisation Programme, the measles-rubella (MR) vaccine is provided as two doses. Maintaining high coverage for both doses is essential because it is the combination that maximises long-term protection and reduces the likelihood of outbreaks. Public health messaging increasingly focuses on ensuring the second dose is not missed, particularly as families move between districts or rely on irregular healthcare access.
For parents and caregivers, the practical takeaway is straightforward: ensure children receive MR vaccinations on schedule, and treat fever-and-rash illness seriously by seeking medical guidance. For policymakers, the longer-term task is to keep strengthening surveillance, outbreak response capacity and last-mile immunisation delivery to meet elimination targets.
- Provisional WHO-linked data cited 8,035 measles cases for India (Apr–Oct 2025)
- India running a measles-rubella elimination campaign aimed at 2026 goals
- Focus areas: two-dose coverage, surveillance, outreach to high-risk and mobile populations